Table 2 Description of WTP study characteristics
From: Men’s willingness to pay for prostate cancer screening: a systematic review
Author/year | Country | Study aim | Respondents (N = sample size) | Response rate | Examination test | CVM techniques | Regression model | Significant factors | Number of scenarios | Statistical measure |
|---|---|---|---|---|---|---|---|---|---|---|
Neumannet al. 2010 [18] | USA | Assesses how much people would pay for a laboratory test that predicted their future disease status. | 688 men without symptoms—age not presented | 0.96% | Predictive test | Double-bounded, dichotomous-choice approach | Logistic regression and maximum likelihood regression | Age (negative) Household Income (positive) Risk score (positive) Education (negative) Gender (positive) | 2 | Median $263 for perfect and mean $622 for the perfect prostate cancer test in risk disease 25% |
Yasunaga 2008 [19] | Japan | Estimating the willingness to pay (WTP) for prostate cancer screening with prostate-specific antigen (PSA). | 400 men without symptoms aged 50–59 | 0.33% | PSA | A double bound dichotomous choice approach | Weibull regression analysis | Age (positive) Annual household income (positive) Family history of cancer (positive) | 1 | The mean WTP was ¥1670 ($15.2) |
Yasunaga et al. 2006 [20] | Japan | Verifying this hypothesis that having sufficient information will reduce men’s desire for screening. | 137 men without symptoms aged 40–59 | 0.36% | PSA | Payment Card | Categorical regression analysis | Age (positive) Household income (positive) Hospitalization History (positive) | 1 | The mean WTP for prostate-specific antigen screening was $18.90 |
Yasunaga et al. 2011 [21] | Japan | Comparing the WTP between well-informed and ill-informed men to pay for PSA screening. | 1800 men without symptoms aged 50–69 years | 0.50% | PSA | Double-bound dichotomous choice method. | Weibull regression analysis | Household income (positive) history of receiving PSA screening (positive) | The average WTP was significantly greater in group 1 than in group 2 ($31.1 vs. $25.1,) | |
Pedersen et al. 2011 [22] | Denmark | Assessing the impact of public and private health care services, and the extent to which negative information on the PSA-test influences the perceptions of the screening programmed. | 1535 men without symptoms aged 50–70 years | 0.40% | PSA | Double bounded dichotomous choice | multiple regression | Household income (positive) Employment (negative) Prior PSA-test (negative) User fees (positive) | 3 | Full sample—excluding protesters (DDK) Public provision and low information = 85.3 |
Mayer et al. 2018 [23] | German | Achieving insight into men’s attitudes in genetic testing for PCa. | 4699 prostate cancer patients | 0.70% | PSA | Double bounded dichotomous choice | logistic regression | Self-reported economic situation (positive) Family history (positive) Education (positive) | 3 | Up to 500 Euro |